[go: up one dir, main page]

NO940913L - Preparater for kontrollert frigivelse av biologisk aktiv TGF- - Google Patents

Preparater for kontrollert frigivelse av biologisk aktiv TGF-

Info

Publication number
NO940913L
NO940913L NO940913A NO940913A NO940913L NO 940913 L NO940913 L NO 940913L NO 940913 A NO940913 A NO 940913A NO 940913 A NO940913 A NO 940913A NO 940913 L NO940913 L NO 940913L
Authority
NO
Norway
Prior art keywords
compositions
tgf
improved surgical
bone tissue
implant devices
Prior art date
Application number
NO940913A
Other languages
English (en)
Other versions
NO940913D0 (no
Inventor
Wayne Richard Gombotz
Lisa Servito Bouchard
Susan Carol Pankey
Michael E Hawkins
Anthony F Purchio
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO940913D0 publication Critical patent/NO940913D0/no
Publication of NO940913L publication Critical patent/NO940913L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Keramiske og polymerbaserte preparater som styrer den kontrollerte vedvarende frigjøring av TGF-0 til benvev og forbedrede kirurgiske implantatinnretninger som inkorporerer slike preparater beskrives. Preparatene og de forbedrede kirurgiske implantatinnretninger ifølge oppfin- nelsen induserer og/eller forbedrer osteogeneseprosessen i animalt benvev hvilket resulterer i dannelsen av nytt modent ben, og de er egnet til utbedring av ortopediske og periodontale benvevsdefekter. Flere spesielle utførelses- former beskrives og disse er eksempler som illustrerer fremgangsmåtene til fremstilling av preparatene og for- bedrede kirurgiske implantater, preparatenes TGF-p-fri- gjøringskinetiske egenskaper, og preparatenes effektivitet og forbedrede kirurgiske implantatinnretninger i dyre- modeller. I en slik spesiell utførelsesform, utbedres en kritisk defekt som er introdusert i en rotteskalle, ved anvendelse av et keramisk basert TGF-B-tilførselspreparat.
NO940913A 1993-03-26 1994-03-15 Preparater for kontrollert frigivelse av biologisk aktiv TGF- NO940913L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3778693A 1993-03-26 1993-03-26

Publications (2)

Publication Number Publication Date
NO940913D0 NO940913D0 (no) 1994-03-15
NO940913L true NO940913L (no) 1994-09-27

Family

ID=21896328

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940913A NO940913L (no) 1993-03-26 1994-03-15 Preparater for kontrollert frigivelse av biologisk aktiv TGF-

Country Status (7)

Country Link
EP (1) EP0616814A1 (no)
JP (1) JPH072691A (no)
AU (1) AU5905694A (no)
CA (1) CA2119090A1 (no)
FI (1) FI941396L (no)
IL (1) IL109032A0 (no)
NO (1) NO940913L (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
GB9407135D0 (en) * 1994-04-11 1994-06-01 Aberdeen University And Plasma Treatment of osteoporosis
GB2301531B (en) * 1994-04-11 1997-12-17 Univ Aberdeen Intraosseus injection device
US5591453A (en) * 1994-07-27 1997-01-07 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US5817327A (en) * 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
JPH08193997A (ja) * 1995-01-18 1996-07-30 Mitsubishi Materials Corp 活性型ＴＧＦ−β１の吸着剤、活性型ＴＧＦ−β１の検査法及び癌の検査法
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
JP2936314B2 (ja) 1995-12-06 1999-08-23 旭土建株式会社 保水性ネット
ES2334726T3 (es) * 1996-02-09 2010-03-15 Amgen Inc. Composicion que comprende il-1ra como inhibidor de interleucina 1 e hialuronano como polimero de liberacion controlada.
EP0934087B1 (en) * 1996-10-24 2007-03-21 SDGI Holdings, Inc. Ceramic fusion implants and compositions containing osteoinductive factors
US6037519A (en) * 1997-10-20 2000-03-14 Sdgi Holdings, Inc. Ceramic fusion implants and compositions
US20030032586A1 (en) * 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
EP0902036A1 (en) 1997-09-05 1999-03-17 Roche Diagnostics GmbH Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6911553B1 (en) 1997-10-02 2005-06-28 Roche Diagnostics Gmbh Osteoblast-specific mitogens and drugs containing such compounds
EP0906759A1 (de) 1997-10-02 1999-04-07 Roche Diagnostics GmbH Neue Osteoblastenspezifische Mitogene: Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
NL1008582C2 (nl) * 1998-01-05 1999-07-06 Vrije Universiteit Botmateriaal.
AU3556400A (en) 1999-03-17 2000-10-04 Novartis Ag Pharmaceutical compositions
US6726718B1 (en) * 1999-12-13 2004-04-27 St. Jude Medical, Inc. Medical articles prepared for cell adhesion
WO2002016557A2 (en) 2000-08-21 2002-02-28 Rice University Tissue engineering scaffolds promoting matrix protein production
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
GB0110726D0 (en) 2001-05-02 2001-06-27 Biocomposites Ltd Bone implant composition
US8496955B2 (en) 2001-05-02 2013-07-30 Biocomposites Limited Calcium phosphate/sulfate-based bone implant composition
US7371258B2 (en) 2001-10-26 2008-05-13 St. Jude Medical, Inc. Valved prosthesis with porous substrate
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
PE20061329A1 (es) 2004-12-15 2006-12-08 Neuralab Ltd Anticuerpos ab humanizados para mejorar la cognicion
DE102005040429A1 (de) * 2005-08-25 2007-03-01 Heraeus Kulzer Gmbh Wirkstofffreisetzungssystem und seine Verwendung
WO2007113682A2 (en) * 2006-04-06 2007-10-11 Novozymes Gropep Ltd Tgf-beta pharmaceutical compositions
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8133553B2 (en) 2007-06-18 2012-03-13 Zimmer, Inc. Process for forming a ceramic layer
US8309521B2 (en) 2007-06-19 2012-11-13 Zimmer, Inc. Spacer with a coating thereon for use with an implant device
US8608049B2 (en) 2007-10-10 2013-12-17 Zimmer, Inc. Method for bonding a tantalum structure to a cobalt-alloy substrate
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
GB0809592D0 (en) * 2008-05-27 2008-07-02 Imp Innovations Ltd Biomaterials
CA2653866A1 (en) * 2008-07-03 2010-01-03 Induce Biologics Inc. Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
GB0911365D0 (en) 2009-06-30 2009-08-12 Bioceramic Therapeutics Ltd Multicomponent glasses for use as coatings and in personal care products
CA2817584C (en) 2010-11-15 2018-01-02 Zimmer Orthobiologics, Inc. Bone void fillers
WO2012105223A1 (ja) * 2011-01-31 2012-08-09 オリンパス株式会社 免疫賦活剤
US20170252480A1 (en) 2014-09-01 2017-09-07 Kyushu University, National University Corporation Method of producing product inorganic compound and product inorganic compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
NL8401061A (nl) * 1984-04-04 1985-11-01 Stichting Biomaterials Science Werkwijze voor het bereiden van een implantatiemateriaal dat geneesmiddelen afgeeft in het lichaam.
US5108436A (en) * 1988-09-29 1992-04-28 Collagen Corporation Implant fixation
IE61346B1 (en) * 1988-11-02 1994-11-02 Genentech Inc A permeable material to fit around the teeth or gums of a mammal
US4976736A (en) * 1989-04-28 1990-12-11 Interpore International Coated biomaterials and methods for making same
WO1990015586A2 (en) * 1989-06-05 1990-12-27 Massachusetts Institute Of Technology Bioerodible polymers for drug delivery in bone
ZA923086B (en) * 1991-04-29 1993-10-28 South African Medical Research A delivery system for biologicaly active growth or morphogenetic factors and a method for preparing such delivery system
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone

Also Published As

Publication number Publication date
FI941396A0 (fi) 1994-03-25
JPH072691A (ja) 1995-01-06
FI941396A7 (fi) 1994-09-27
EP0616814A1 (en) 1994-09-28
FI941396L (fi) 1994-09-27
NO940913D0 (no) 1994-03-15
CA2119090A1 (en) 1994-09-27
AU5905694A (en) 1994-09-29
IL109032A0 (en) 1994-06-24

Similar Documents

Publication Publication Date Title
NO940913L (no) Preparater for kontrollert frigivelse av biologisk aktiv TGF-
Rosenberg et al. Biologic and clinical considerations for autografts and allografts in periodontal regeneration therapy
Aaboe et al. Healing of experimentally created defects: a review
Srouji et al. Mandibular defect repair by TGF-β and IGF-1 released from a biodegradable osteoconductive hydrogel
AU718801B2 (en) Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
Kao et al. The use of biologic mediators and tissue engineering in dentistry.
Schnettler et al. Bone ingrowth in bFGF-coated hydroxyapatite ceramic implants
US5422340A (en) TGF-βformulation for inducing bone growth
KIRKER‐HEAD Recombinant bone morphogenetic proteins: novel substances for enhancing bone healing
EP1448246B1 (en) Homogeneously coated device having osteoinductive and osteoconductive properties
Jung et al. Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material.
Zellin et al. Opposite effects of recombinant human transforming growth factor-β1 on bone regeneration in vivo: effects of exclusion of periosteal cells by microporous membrane
Shin et al. Periodontal regeneration: Current therapies
Rabie et al. Integration of endochondral bone grafts in the presence of demineralized bone matrix
Wikesjö et al. Periodontal repair in dogs: Space‐providing ePTFE devices increase rhBMP‐2/ACS‐induced bone formation
Nevins et al. Localized bone reconstruction as an adjunct to dental implant placement
Bubalo et al. The use of collagen membranes in guided tissue regeneration
Sandor et al. Bone regeneration of the cranio-maxillofacial and dento-alveolar skeletons in the framework of tissue engineering
Guzzardella et al. Laser technology in orthopedics: preliminary study on low power laser therapy to improve the bone-biomaterial interface
Pinheiro et al. Effect of 830-nm laser light on the repair of bone defects grafted with inorganic bovine bone and decalcified cortical osseus membrane
Guizzardi et al. Qualitative assessment of natural apatite in vitro and in vivo
US6884518B2 (en) Material suitable for an individual's tissue reconstruction
Harsini et al. Bone grafting and the materials for using in orthopaedics
Sheikh et al. Bone grafting
Bedeloğlu et al. Vascular endothelial growth factor and biphasic calcium phosphate in the endosseous healing of femoral defects: An experimental rat study